Right you are! PROVE 1 and 2 didn't enroll cirrhotic patients, and as you've previously posted in #msg-37316151, it is an important and surprising finding. One expects that absorption of a PIs should varied significantly by fibrosis score in patients with advanced fibrosis/cirrhosis. This is important as this subgroup is among the hardest patients to treat.
Market Data 
Markets 
AI
